TipRanks
Xeris Pharmaceuticals (DE:2B30)
FRANKFURT:2B30

Compare Xeris Pharmaceuticals (2B30) vs. Competitors

0 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Xeris Pharmaceuticals
€7.14
€1.50B
-93.51
20.66%
5 Buy
1 Hold
0 Sell
Strong Buy
Syndax Pharmaceuticals
$20.09
$1.63B
-6.98
13.99%
10 Buy
0 Hold
0 Sell
Strong Buy
Zymeworks
$27.47
$1.86B
-12.45
48.82%
13 Buy
0 Hold
0 Sell
Strong Buy
Arcus Biosciences
$30.59
$3.21B
-6.22
82.80%
8 Buy
3 Hold
0 Sell
Moderate Buy
Stoke Therapeutics
$33.09
$1.68B
-7.63
3.22%
10 Buy
0 Hold
0 Sell
Strong Buy
Rapport Therapeutics, Inc.
$52.50
$1.58B
-10.58
12.72%
9 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:2B30
Xeris Pharmaceuticals
8.10
1.22
17.67%
SNDX
Syndax Pharmaceuticals
17.60
1.20
7.32%
ZYME
Zymeworks
25.15
8.47
50.73%
RCUS
Arcus Biosciences
24.44
9.96
68.78%
STOK
Stoke Therapeutics
25.62
-1.19
-4.44%
RAPP
Rapport Therapeutics, Inc.
32.17
4.43
15.97%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts